Golden State Equity Partners’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Golden State Equity Partners's BEAM Position: Q3 2026 in Review
Golden State Equity Partners opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 43 shares worth $1.05K. The stake represents ﹤0.01% of the portfolio and ranks #1989 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in BEAM as recently as Q1 2026.
Golden State Equity Partners first reported a position in BEAM in Q4 2021 and has held it in 5 quarters since. The position peaked at $555K in Q1 2022. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Golden State Equity Partners held 43 shares of Beam Therapeutics worth $1.05K as of Q3 2026.
- Beam Therapeutics was a new Golden State Equity Partners position in Q3 2026.
- Beam Therapeutics made up ﹤0.01% of Golden State Equity Partners's portfolio in Q3 2026, its #1989 holding.
- Golden State Equity Partners first reported a position in Beam Therapeutics in Q4 2021 and has held it in 5 quarters since.
- Golden State Equity Partners's Beam Therapeutics position peaked at $555K in Q1 2022.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.